Vera Therapeutics, Inc. (VERA)

NGM – Цена в реальном времени. Валюта: USD

36.70

+0.09 (0.25%)

При закрытии: May 12, 2026, 4:00 PM EDT

36.78

+0.08 (0.22%)

После закрытия: May 12, 2026, 7:52 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Vera Therapeutics, Inc. (VERA)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Vera Therapeutics, Inc. (VERA)

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer

Видео

No Data

Пресс-релизы

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Search stocks

Vera Therapeutics, Inc. (VERA)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Vera Therapeutics, Inc. (VERA)

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer

Видео

No Data

Пресс-релизы

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)